Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	May 31, 2024	May 31, 2023
Cash Flows From Operating Activities:
Net income (loss) available to common shareholders	$ (36,796)	$ 24,922
Dividends on preferred stock	1,200	3,600
Plus: Redemption premium on Series A Preferred Stock	75,198	0
Net income from continuing operations	39,602	28,522
Adjustments to reconcile net income to net cash provided by operating activities:
Bad debt expense	330	18
Depreciation and amortization	20,323	18,524
Deferred income taxes	3,164	(2,022)
Equity in earnings of unconsolidated entities	(3,824)	(1,420)
Distribution on investment in AVAIL joint venture	539	0
Net loss (gain) on sale of property, plant and equipment	(16)	(2)
Amortization of debt financing costs	3,109	3,029
Share-based compensation expense	2,535	1,904
Changes in current assets and current liabilities	7,610	(1,002)
Changes in other long-term assets and long-term liabilities	(1,428)	(658)
Net cash provided by operating activities	71,944	46,893
Cash flows from investing activities
Purchase of property, plant and equipment	(27,396)	(17,036)
Other investing activities	17	9
Net cash used in investing activities	(27,379)	(17,027)
Cash flows from financing activities:
Proceeds from secondary public offering and issuance of additional common stock	308,723	0
Redemption of Series A Preferred Stock	(308,920)	0
Payments for taxes related to net share settlement of equity awards	(4,567)	(1,710)
Proceeds from revolving loan	75,000	92,000
Payments on revolving loan	(70,000)	(112,000)
Payments of debt financing costs	(715)	0
Payments on long term debt and finance lease liabilities	(30,196)	0
Payments of dividends	(7,867)	(7,835)
Net cash used in financing activities	(38,542)	(29,545)
Effect of exchange rate changes on cash	174	737
Net increase in cash and cash equivalents	6,197	1,058
Cash and cash equivalents at beginning of period	4,349	2,820
Cash and cash equivalents at end of period	$ 10,546	$ 3,878